Quantum Biopharma ( (TSE:QNTM) ) has issued an update.
On March 20, 2025, Quantum BioPharma announced the purchase of an additional USD $1,500,000 in Bitcoin and other cryptocurrencies, bringing its total crypto assets to USD $3,500,000. This strategic move is part of the company’s efforts to diversify its treasury and leverage cryptocurrencies for potential returns and as a hedge against the dollar. The company is set up to conduct transactions and receive financing in cryptocurrencies, ensuring compliance with financial regulations. This decision reflects Quantum BioPharma’s confidence in the potential of cryptocurrencies to enhance its financial operations and provide value to shareholders.
More about Quantum Biopharma
Quantum BioPharma is a biopharmaceutical company focused on developing innovative biotech solutions for treating neurodegenerative and metabolic disorders, as well as alcohol misuse disorders. The company is engaged in research and development through its subsidiary Lucid Psycheceuticals Inc., with a lead compound, Lucid-MS, aimed at addressing multiple sclerosis. Quantum BioPharma also holds a stake in Celly Nutrition Corp. and maintains strategic investments through FSD Strategic Investments Inc.
YTD Price Performance: 63.24%
Average Trading Volume: 2,657,469
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $12.32M
For a thorough assessment of QNTM stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com